Alexopoulos, G. S. et al. (1997). Vascular depression’ hypothesis. Archives of General Psychiatry, 54, 915–922.
Almeida, O. P., McCaul, K., Hankey, G. J., Yeap, B. B., Golledge, J. and Flicker, L. (2016). Risk of dementia and death in community-dwelling older men with bipolar disorder. British Journal of Psychiatry, 209, 121–126.
Almeida, O., Hankey, G., Yeap, B., Golledge, J. and Flicker, L. (2017). Depression as a modifiable factor to decrease the risk of dementia. Translational Psychiatry, 7, e1117, doi:10.1038/tp.2017.90.
Apostolova, L. G. et al. (2014). Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 37, 315–326.
Apostolova, L. G. and Cummings, J. L. (2008). Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dementia and Geriatric Cognitive Disorders, 25, 115–126.
Babulal, G. M. et al. (2016). Mood changes in cognitively normal older adults are linked to alzheimer disease biomarker levels. The American Journal of Geriatric Psychiatry, 24, 1095–1104.
Bakchine, S., Lacomblez, L., Benoit, N., Parisot, D., Chain, F. and Lhermitte, F. (1989). Manic-like state after bilateral orbitofrontal and right temporoparietal injury: efficacy of clonidine. Neurology, 39, 777–781.
Ballmaier, M. et al. (2008). Hippocampal morphology and distinguishing late-onset from early-onset elderly depression. American Journal of Psychiatry, 165, 229–237.
Balthazar, M. L. et al. (2013). Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network. Hum Brain Mapp, 35, 1237–1246.
Barnes, D. E., Yaffe, K., Byers, A. L., McCormick, M., Schaefer, C. and Whitmer, R. A. (2012). Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Archives of General Psychiatry, 69, 493– 498.
Batelaan, N. M., Seldenrijk, A., Bot, M., van Balkom, A. J. L. M. and Penninx, B. W. J. H. (2016). Anxiety and new onset of cardiovascular disease: critical review and meta-analysis. The British Journal of Psychiatry, 208, 223–231.
Beaudreau, S. A. and O'Hara, R. (2008). Late-life anxiety and cognitive impairment: a review. American Journal of Geriatric Psychiatry, 16, 790–803.
Brooks, J. O. 3rd and Hoblyn, J. C. (2005). Secondary mania in older adults. American Journal of Psychiatry, 162, 2033–2038.
Burke, S. L., Maramaldi, P., Cadet, T. and Kukull, W. (2016). Neuropsychiatric symptoms and Apolipoprotein E: associations with eventual Alzheimer's disease development. Archives of Gerontology and Geriatrics, 65, 231–238.
Burns, A. (1992). Psychiatric phenomena in dementia of the Alzheimer type. International Psychogeriatrics, 4 (Suppl. 1), S43–S54.
Castrén, E. and Kojima, M. (2017). Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiology of Disease, 97, 119–126.
Cerami, C., Marcone, A., Galimberti, D., Villa, C., Scarpini, E. and Cappa, S. F. (2011). From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder. Journal of Alzheimer's Disease, 27, 791–797.
Cerejeira, J., Lagarto, L. and Mukaetova-Ladinska, E. B. (2012). Behavioral and psychological symptoms of dementia. Frontiers of Neurology, 3, 73.
Cooper, C., Sommerlad, A., Lyketsos, C. G. and Livingston, G. (2015). Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. American Journal of Psychiatry, 172, 323–334.
Danel, T. et al. (1989). [Mood disorders and right hemisphere infarction]. Encephale, 15, 549–553.
De Winter, F.-L. et al. (2016). No association of lower hippocampal volume with alzheimer's disease pathology in late-life depression. American Journal of Psychiatry, doi: 10.1176/appi.ajp.2016.16030319.
DeLuca, A. K. et al. (2005). Comorbid anxiety disorder in late life depression: association with memory decline over four years. International Journal of Geriatric Psychiatry, 20, 848–854.
Devier, D. J. et al. (2009). The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease. International Journal of Geriatric Psychiatry, 24, 1335–1342.
Dhingra, U. and Rabins, P. V. (1991). Mania in the elderly: a 5–7 year follow-up. Journal of the American Geriatrics Society, 39, 581–583.
Dols, A., Krudop, W., Moller, C., Shulman, K., Sajatovic, M. and Pijnenburg, Y. A. (2016). Late life bipolar disorder evolving into frontotemporal dementia mimic. Neuropsychiatric Disease and Treatment, 12, 2207–2212.
Domingos da Silveira da Luz, A. C. et al. (2013). Translational findings on brain-derived neurotrophic factor and anxiety: contributions from basic research to clinical practice. Neuropsychobiology, 68, 129–138.
Donovan, N. J. et al. (2014). Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of alzheimer disease. The American Journal of Geriatric Psychiatry, 22, 1642–1651.
Donovan, N. J. et al. (2015). Depressive symptoms and biomarkers of Alzheimer's disease in cognitively normal older adults. Journal of Alzheimer's Disease, 46, 63–73.
Erickson, K., Drevets, W. and Schulkin, J. (2003). Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neuroscience & Biobehavioral Reviews, 27, 233–246.
Ferretti, L., McCurry, S. M., Logsdon, R., Gibbons, L. and Teri, L. (2001). Anxiety and Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 14, 52–58.
Floris, G. et al. (2013). Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders?. Journal of Neurology, 260, 1155–1157.
Forrester, S. N., Gallo, J. J., Smith, G. S. and Leoutsakos, J. M. (2016). Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia. American Journal of Geriatric Psychiatry, 24, 117–125.
Fujikawa, T., Yamawaki, S. and Touhouda, Y. (1995). Silent cerebral infarctions in patients with late-onset mania. Stroke, 26, 946–949.
Furtado, M. and Katzman, M. A. (2015) Neuroinflammatory pathways in anxiety, posttraumatic stress, and obsessive compulsive disorders. Psychiatry Research, 229, 37–48.
Gallacher, J. et al. (2009). Does anxiety affect risk of dementia? findings from the Caerphilly prospective study. Psychosomatic Medicine, 71, 659–666.
Gatchel, J. R. et al. (2017). Depressive symptoms and tau accumulation in the inferior temporal lobe and entorhinal cortex in cognitively normal older adults: a pilot study. Journal of Alzheimer's Disease, 59, 975–985.
Geda, Y. E. et al. (2014). Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. American Journal of Psychiatry, 171, 572–581.
Gerritsen, L., Comijs, H. C., van der Graaf, Y., Knoops, A. J., Penninx, B. W. and Geerlings, M. I. (2011). Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes—the SMART Medea study. Biological Psychiatry, 70, 373–380.
Gonzales, M. M. et al. (2017). Cortical atrophy is associated with accelerated cognitive decline in mild cognitive impairment with subsyndromal depression. The American Journal of Geriatric Psychiatry, 25, 980–991.
Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L. and LaFerla, F. M. (2006). Glucocorticoids increase amyloid-β and Tau pathology in a mouse model of Alzheimer's disease. The Journal of Neuroscience, 26, 9047–9056.
Gulpers, B., Ramakers, I., Hamel, R., Kohler, S., Oude Voshaar, R. and Verhey, F. (2016). Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis. American Journal of Geriatric Psychiatry, 24, 823–842.
Hashimoto, H. et al. (2006). Anxiety and regional cortical glucose metabolism in patients with Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 521–528.
Hermida, A. P., McDonald, W. M., Steenland, K. and Levey, A. (2012). The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?. Expert Review of Neurotherapeutics, 12, 1339–1350.
Ismail, Z. et al. (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimer's & Dementia, 12, 195–202.
Ismail, Z. et al. (2017a). The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. Journal of Alzheimer's Disease, 56, 929–938.
Ismail, Z. et al. (2017b). Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. Jama Psychiatry, 74, 58–67.
Ismail, Z., Malick, A., Smith, E. E., Schweizer, T. and Fischer, C. (2014). Depression versus dementia: is this construct still relevant?. Neurodegenerative Disease Management, 4, 119–126.
Jalal, H., Ganesh, A., Lau, R., Lysack, J. and Ismail, Z. (2014). Cholinesterase-inhibitor associated mania: a case report and literature review. The Canadian Journal of Neurological Sciences, 41, 278–280.
Karttunen, K. et al. (2011). Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease. International Journal of Geriatric Psychiatry, 26, 473–482.
Krauthammer, C. and Klerman, G. L. (1978). Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Archives of General Psychiatry, 35, 1333–1339.
Krell-Roesch, J. et al. (2016). FDG-PET and neuropsychiatric symptoms among cognitively normal elderly persons: the mayo clinic study of aging. Journal of Alzheimer's Disease, 53, 1609–1616.
Krishnan, K. R., Hays, J. C. and Blazer, D. G. (1997). MRI-defined vascular depression. American Journal of Psychiatry, 154, 497–501.
Lambiase, M. J., Kubzansky, L. D. and Thurston, R. C. (2014). Prospective study of anxiety and incident stroke. Stroke, 45, 438–443.
Leininger, S. and Skeel, R. (2012). Cortisol and self-report measures of anxiety as predictors of neuropsychological performance. Archives of Clinical Neuropsychology, 27, 318–328.
Leoutsakos, J. M., Forrester, S. N., Lyketsos, C. G. and Smith, G. S. (2015). Latent classes of neuropsychiatric symptoms in NACC controls and conversion to mild cognitive impairment or dementia. Journal of Alzheimer's Disease, 48, 483–493.
Levenson, R. W., Sturm, V. E. and Haase, C. M. (2014). Emotional and behavioral symptoms in neurodegenerative disease: a model for studying the neural bases of psychopathology. Annual Review of Clinical Psychology, 10, 581–606.
Li, X. X. and Li, Z. (2017). The impact of anxiety on the progression of mild cognitive impairment to dementia in Chinese and English data bases: a systematic review and meta-analysis. International Journal of Geriatric Psychiatry, doi:10.1002/gps.4694.
Lin, W. C., Hu, L. Y., Tsai, S. J., Yang, A. C. and Shen, C. C. (2017). Depression and the risk of vascular dementia: a population‐based retrospective cohort study. International Journal of Geriatric Psychiatry, 32, 556–563.
Lobo, A. et al. (2008). Non-cognitive psychopathological symptoms assoc w MCI and AD. Neurotoxicity Research, 14, 263–272.
Lopez-Anton, R. et al. (2015). Mild cognitive impairment diagnosed with the new DSM-5 criteria: prevalence and associations with non-cognitive psychopathology. Acta Psychiatrica Scandinavica, 131, 29–39.
Lyketsos, C. G., Corazzini, K. and Steele, C. (1995). Mania in Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 350–352.
Mah, L., Binns, M. A. and Steffens, D. C. (2015). Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to alzheimer disease. The American Journal of Geriatric Psychiatry, 23, 466–476.
Mantella, R. C. et al. (2008). Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology, 33, 773–781.
Masters, M. C., Morris, J. C. and Roe, C. M. (2015). “Noncognitive” symptoms of early Alzheimer disease a longitudinal analysis. Neurology, 84, 1–6.
McCutcheon, S. T. et al. (2016). Clinicopathological correlates of depression in early Alzheimer's disease in the NACC. International Journal of Geriatric Psychiatry, 31, 1301–1311.
Mortby, M. E., Burns, R., Eramudugolla, R., Ismail, Z. and Anstey, K. J. (2017). Neuropsychiatric symptoms and cognitive impariment: understanding the importance of co-morbid symptoms. Journal of Alzheimer's Disease, 1–13.
Ng, K. P. et al. (2017). Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease. Neurology, 88, 1814–1821.
O'Brien, J. (2003). Behavioral symptoms in vascular cognitive impairment and vascular dementia. International Psychogeriatrics, 15, 133–138.
Palmer, K. et al. (2010). Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. Journal of Alzheimer's Disease, 20, 175–183.
Palmer, K., Berger, A. K., Monastero, R., Winblad, B., Backman, L. and Fratiglioni, L. (2007). Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology, 68, 1596–1602.
Peters, M. E. et al. (2012). Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the cache county study. The American Journal of Geriatric Psychiatry, 20, 416–424.
Peters, M. E. et al. (2013). Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the cache county study. American Journal of Geriatric Psychiatry, 21, 1116–1124.
Pietrzak, R. H. et al. (2012). Mild worry symptoms predict decline in learning and memory in healthy older adults: a 2-year prospective cohort study. The American Journal of Geriatric Psychiatry, 20, 266–275.
Pomara, N. et al. (2012). Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. American Journal of Psychiatry, 169, 523–530.
Rabins, P. V. et al. (2013). Predictors of progression to severe Alzheimer's disease in an incidence sample. Alzheimers Dementia, 9, 204–207.
Ramirez-Bermudez, J. et al. (2016). [White matter hyperintensities and cognitive function in patients with late onset mania]. Gaceta medica de Mexico, 152, 592–600.
Reichenberg, A. et al. (2001). Cytokine-associated emotional and cognitive disturbances in humans. Archives of General Psychiatry, 58, 445–452.
Robert, P. H. et al. (2006). Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study. Clinical Neurology and Neurosurgery, 108, 733–736.
Robinson, R. G. (1997). Mood disorders secondary to stroke. Seminars in Clinical Neuropsychiatry, 2, 244–251.
Rosenberg, P. B. (2017). New Insights Into Brain Mechanisms Underlying Neuropsychiatric Symptoms in Alzheimer's Disease. Elsevier.
Rosenberg, P. B., Mielke, M. M., Appleby, B. S., Oh, E. S., Geda, Y. E. and Lyketsos, C. G. (2013). The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. The American Journal of Geriatric Psychiatry, 21, 685–695.
Rosenberg, P. B., Nowrangi, M. A. and Lyketsos, C. G. (2015). Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?. Molecular Aspects of Medicine, 43–44, 25–37.
Rosnick, C. B., Rawson, K. S., Butters, M. A. and Lenze, E. J. (2013). Association of cortisol with neuropsychological assessment in older adults with generalized anxiety disorder. Aging & Mental Health, 17, 432–440.
Rozzini, L. et al. (2007). Conversion of amnestic mild cognitive impairment to dementia of Alzheimer type is independent to memory deterioration. International Journal of Geriatric Psychiatry, 22, 1217–1222.
Sajatovic, M. et al. (2015). A report on older-age bipolar disorder from the international society for bipolar disorders task force. International Journal of Bipolar Disorders, 17, 689–704.
Sami, M., Khan, H. and Nilforooshan, R. (2015). Late onset mania as an organic syndrome: a review of case reports in the literature. Journal of Affective Disorders, 188, 226–231.
Sapolsky, R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry, 57, 925–935.
Savva, G. M. et al. (2009). Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. British Journal of Psychiatry, 194, 212–219.
Seignourel, P. J., Kunik, M. E., Snow, L., Wilson, N. and Stanley, M. (2008). Anxiety in dementia: a critical review. Clinical Psychology Review, 28, 1071–1082.
Sheline, Y. I., Sanghavi, M., Mintun, M. A. and Gado, M. H. (1999). Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. Journal of Neuroscience, 19, 5034–5043.
Sheps, D. S. and Sheffield, D. (2001). Depression, anxiety, and the cardiovascular system: the cardiologist's perspective. Journal of Clinical Psychiatry, 62 (Suppl. 8), 12–16; discussion 17–18.
Singh-Manoux, A. et al. (2017). Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiatry.
Sinoff, G. and Werner, P. (2003). Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline. International Journal of Geriatric Psychiatry, 18, 951–959.
Sousa, M. F., Santos, R. L., Turro-Garriga, O., Dias, R., Dourado, M. C. and Conde-Sala, J. L. (2016). Factors associated with caregiver burden: comparative study between Brazilian and Spanish caregivers of patients with Alzheimer's disease (AD). International Psychogeriatrics, 28, 1363–1374.
Spalletta, G., Musicco, M., Padovani, A., Rozzini, L., Perri, R. and Fadda, L. (2010). Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. International Journal of Geriatric Psychiatry, 18, 1026–1035.
Starkstein, S. E. and Robinson, R. G. (1997). Mechanism of disinhibition after brain lesions. Journal of Nervous and Mental Disease, 185, 108–114.
Steenland, K., Karnes, C., Seals, R., Carnevale, C., Hermida, A. and Levey, A. (2012). Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. Journal of Alzheimer's Disease, 31, 265–275.
Steffens, D. C. and Krishnan, K. R. (1998). Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biological Psychiatry, 43, 705–712.
Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurology, 11, 1006–1012.
Stone, K. (1989). Mania in the elderly. British Journal of Psychiatry, 155, 220–224.
Tapiainen, V., Hartikainen, S., Taipale, H., Tiihonen, J. and Tolppanen, A.-M. (2017). Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: a nationwide nested case-control study. European Psychiatry, 43, 92–98.
Taragano, F. E., Allegri, R. F., Krupitzki, H., Sarasola, D., Serrano, C. and Lyketsos, C. (2009). Mild behavioral impairment. Journal of Clinical Psychiatry, 70, 584–592.
Tascone, L. d. S. and Bottino, C. M. d. C. (2013). Neurobiology of neuropsychiatric symtoms in Alzheimer's disease: a critical review wiht a focus on neuroimaging. Dement Neuropsychol, 7, 236–243.
Teixeira, A. L., Barbosa, I. G., Diniz, B. S. and Kummer, A. (2010). Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomarkers in Medicine, 4, 871–887.
Tighe, S. K. et al. (2012). Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 24, 484–488.
Ting, C. et al. (2010). Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life. PloS One, 5, e10151.
Tohen, M., Shulman, K. I. and Satlin, A. (1994). First-episode mania in late life. American Journal of Psychiatry, 151, 130–132.
Turecki, G., Mari Jde, J. and Del Porto, J. A. (1993). Bipolar disorder following a left basal-ganglia stroke. British Journal of Psychiatry, 163, 690.
Weinstein, G. et al. (2014). Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham heart study. JAMA Neurology, 71, 55–61.
Weissberger, G. H., Melrose, R. J., Narvaez, T. A., Harwood, D., Mandelkern, M. A. and Sultzer, D. L. (2017). 18 F-Fluorodeoxyglucose positron emission tomography cortical metabolic activity associated with distinct agitation behaviors in alzheimer disease. The American Journal of Geriatric Psychiatry, 25, 569–579.
Wilson, R. S. et al. (2014). Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology, 83, 702–709.
Wilson, R., Schneider, J., Bienias, J., Arnold, S., Evans, D. and Bennett, D. (2003). Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology, 61, 1102–1107.
Woolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L. and Rankin, K. P. (2011). The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. Journal of Clinical Psychiatry, 72, 126–133.
Young, R. C. and Klerman, G. L. (1992). Mania in late life: focus on age at onset. American Journal of Psychiatry, 149, 867–876.